These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Study of the action of thioridazine in various chronic depressive and dissociative psychoses]. Soulairac A; Geier S; De Mijolla A; Berouti R Ann Med Psychol (Paris); 1967 Feb; 125(2):258-67. PubMed ID: 6050432 [No Abstract] [Full Text] [Related]
3. [Management of psychotic drive disorders]. Langner E Wien Med Wochenschr; 1968 Sep; 118(36):700-2. PubMed ID: 5679053 [No Abstract] [Full Text] [Related]
4. [Comparative study of the activity of 2 neuroleptics]. Blanc M; Borenstein P; Brion S; Buisson JF; Debray HR; Digo R; Flavigny H; Follin S; Minvielle J; Morel-Maroger A; Pichot P; Rainaut J; Sutter JM Encephale; 1970; 59(2):97-161. PubMed ID: 5458713 [No Abstract] [Full Text] [Related]
5. [On the position of butyrophenone derivative Triperidol in psychiatric treatment]. Lange E; Scholz V Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(6):202-7. PubMed ID: 5731875 [No Abstract] [Full Text] [Related]
6. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics]. Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295 [No Abstract] [Full Text] [Related]
7. Choice of antipsychotic drugs. Hollister LE Am J Psychiatry; 1970 Aug; 127(2):186-90. PubMed ID: 5528794 [No Abstract] [Full Text] [Related]
10. [Thioridazine and its metabolites TPD-6 and TPO-33 Sandoz in the treatment of depressive states]. Bilikiewicz A; Dolmierski R; Sikorski W Psychiatr Pol; 1967; 1(4):447-53. PubMed ID: 4875479 [No Abstract] [Full Text] [Related]
11. Fluphenazine enanthate for the difficult psychotic patient. Stewart AR; Lavallee B Dis Nerv Syst; 1969 Feb; 30(2):98-102. PubMed ID: 5774574 [No Abstract] [Full Text] [Related]
12. [Side effects of methylperone in long-term therapy up to 8 years]. Kirkegaard G; Kirkegaard A Arzneimittelforschung; 1974 Aug; 24(8):1115-7. PubMed ID: 4213783 [No Abstract] [Full Text] [Related]
13. Thioridazine for newly admitted psychiatric patients. Petrides A Curr Ther Res Clin Exp; 1973 Mar; 15(3):116-22. PubMed ID: 4196227 [No Abstract] [Full Text] [Related]
14. [Clinical experience with fluphenazine decanoate in psychoses]. Náhunek K; Rodová A; Svestka J Act Nerv Super (Praha); 1970 Jan; 12(1):47-9. PubMed ID: 5460564 [No Abstract] [Full Text] [Related]
15. [AHR 6134: a new tranquilizer with unexpected results]. Feldmann H; Denber HC Ann Med Psychol (Paris); 1976 Jul; 2(2):269-79. PubMed ID: 1035067 [No Abstract] [Full Text] [Related]
16. Trifluperidol in chronic male psychiatric patients. Serafetinides EA; Colmore JP; Rahhal DK; Clark ML Behav Neuropsychiatry; 1971; 3(1):10-2. PubMed ID: 5566333 [No Abstract] [Full Text] [Related]
17. Fluphenazine enanthate: a report of a clinical trial in psychotic patients. Karkalas Y Curr Ther Res Clin Exp; 1968 Apr; 10(4):196-200. PubMed ID: 4967873 [No Abstract] [Full Text] [Related]
18. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia. Horodnicki JM; Czekalski S; Jarema M Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002 [No Abstract] [Full Text] [Related]
19. Haloperidol and trifluperidol in psychiatry. Drug Ther Bull; 1968 Jul; 6(15):58-9. PubMed ID: 5691291 [No Abstract] [Full Text] [Related]
20. An evaluation of some possible prognostic indicators of response to phenothiazine treatment of acute schizophrenic psychoses. Reznikoff M; Toomey LC Int J Neuropsychiatry; 1965 Aug; 1(4):352-8. PubMed ID: 4379396 [No Abstract] [Full Text] [Related] [Next] [New Search]